OPRX Buybacks
7 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–7; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| OptimizeRx Corp | 2023-12-31 | Reported repurchase cash | $0.00 |
| OptimizeRx Corp | 2023-06-30 | Reported repurchase cash | $7.52M |
| OptimizeRx Corp | 2022-12-31 | Reported repurchase cash | $7.46M |
| OptimizeRx Corp | 2022-06-30 | Reported repurchase cash | $321,054.00 |
| OptimizeRx Corp | 2017-12-31 | Reported repurchase cash | $0.00 |
| OptimizeRx Corp | 2016-12-31 | Reported repurchase cash | $0.00 |
| OptimizeRx Corp | 2016-03-31 | Reported repurchase cash | $357,415.00 |